UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005245
Receipt number R000006237
Scientific Title Early administration of Bifidobacterium bifidum to very low birth weight infants: A Pilot Study
Date of disclosure of the study information 2011/03/14
Last modified on 2017/02/23 11:55:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early administration of Bifidobacterium bifidum to very low birth weight infants: A Pilot Study

Acronym

Early administration of Bifidobacterium to very low birth weight infants

Scientific Title

Early administration of Bifidobacterium bifidum to very low birth weight infants: A Pilot Study

Scientific Title:Acronym

Early administration of Bifidobacterium to very low birth weight infants

Region

Japan


Condition

Condition

Very low birht weight infants

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of early administration of Bifidobacterium bifidum on acceleration of enteral feeding, and on growth of very low birth weight infants.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

the day at total feeding volume reached 100ml/kg/day

Key secondary outcomes

the level of Bifidobacterium in feces from the study infants
growth rate of the study infants
the positive rate of MRSA colonization among the study infants


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Administration of Bifidobacterium within 48h after birth

Interventions/Control_2

Administration of Bifidobacterium more than 48h after birth

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

1 weeks-old >

Gender

Male and Female

Key inclusion criteria

newborn infants with birth weight less than 1500 g

Key exclusion criteria

presence of major congenital malformations
serious infection
lack of parental consent.

Target sample size

36


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Kusuda

Organization

Tokyo Women's Medical University

Division name

Maternal and Perinatal Center

Zip code


Address

8-1 Kawadacho, Shinjuku, Tokyo

TEL

03-5269-7344

Email

kusuda-satoshi@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Kusuda

Organization

Tokyo Women's Medical University

Division name

Neonatology

Zip code


Address

8-1 Kawadacho, Shinjuku, Tokyo

TEL

03-5269-7344

Homepage URL


Email

kusuda-satoshi@umin.ac.jp


Sponsor or person

Institute

Maternal and Perinatal Center,
Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Maternal and Perinatal Center,
Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

none


Other related organizations

Co-sponsor

Meiji Dairies Corporation

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Tokyo Women's Medical University


Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://authorservices.wiley.com/bauthor/terms.asp?ArticleID=997233&auid=

Number of participants that the trial has enrolled


Results

There was no difference in the day total feeding volume reached 100ml/kg/day and the level of Bifidobacterium in feces between the groups. The body weight at discharge tended to be heavier in the eary administration group.
The body weight gain per day during hospitalization in the early adminstration group was higher than that of the control group.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2006 Year 12 Month 31 Day

Date of IRB


Anticipated trial start date

2007 Year 03 Month 01 Day

Last follow-up date

2008 Year 12 Month 01 Day

Date of closure to data entry

2008 Year 12 Month 01 Day

Date trial data considered complete

2008 Year 12 Month 01 Day

Date analysis concluded

2008 Year 12 Month 01 Day


Other

Other related information

No side effect was observed.


Management information

Registered date

2011 Year 03 Month 14 Day

Last modified on

2017 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006237


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name